Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $28,643 | 1,240 | 94.0% |
| Travel and Lodging | $1,730 | 10 | 5.7% |
| Education | $69.11 | 5 | 0.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23.31 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| UCB, Inc. | $2,672 | 109 | $0 (2024) |
| ABBVIE INC. | $2,358 | 109 | $0 (2024) |
| Biogen, Inc. | $2,174 | 97 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $2,151 | 124 | $0 (2024) |
| Allergan, Inc. | $1,794 | 99 | $0 (2022) |
| Novo Nordisk Inc | $1,786 | 100 | $0 (2024) |
| Medtronic USA, Inc. | $1,727 | 26 | $0 (2020) |
| Abbott Laboratories | $1,418 | 16 | $0 (2018) |
| Neurocrine Biosciences, Inc. | $1,051 | 30 | $0 (2024) |
| PFIZER INC. | $936.55 | 45 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $4,433 | 172 | UCB, Inc. ($1,283) |
| 2023 | $3,170 | 150 | AbbVie Inc. ($701.73) |
| 2022 | $3,332 | 167 | ABBVIE INC. ($546.10) |
| 2021 | $3,460 | 161 | AbbVie Inc. ($687.12) |
| 2020 | $3,307 | 153 | Allergan, Inc. ($794.92) |
| 2019 | $4,537 | 152 | Medtronic USA, Inc. ($1,344) |
| 2018 | $4,774 | 151 | Abbott Laboratories ($1,418) |
| 2017 | $3,453 | 150 | Biogen, Inc. ($744.81) |
All Payment Transactions
1,256 individual payment records from CMS Open Payments — Page 1 of 51
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/21/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $43.80 | General |
| Category: Neurology | ||||||
| 12/20/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: PSYCHIATRY | ||||||
| 12/20/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $4.93 | General |
| Category: Neurology | ||||||
| 12/19/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: NEUROLOGY | ||||||
| 12/18/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $16.02 | General |
| Category: Oncology | ||||||
| 12/17/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $38.15 | General |
| Category: Neurology | ||||||
| 12/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $23.55 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $33.53 | General |
| Category: Cardiology | ||||||
| 12/12/2024 | Amneal Pharmaceuticals LLC | CREXONT (Drug) | Food and Beverage | In-kind items and services | $149.99 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Food and Beverage | In-kind items and services | $23.49 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/09/2024 | Biogen, Inc. | LEQEMBI (Drug) | Food and Beverage | In-kind items and services | $25.36 | General |
| Category: Neurology | ||||||
| 12/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.69 | General |
| Category: PAIN | ||||||
| 12/03/2024 | UCB, Inc. | Nayzilam (Drug) | Food and Beverage | In-kind items and services | $21.60 | General |
| Category: Neurology | ||||||
| 12/02/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $14.01 | General |
| Category: PAIN | ||||||
| 11/23/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $47.19 | General |
| Category: Neurology | ||||||
| 11/21/2024 | Neuronetics, Inc. | NEUROSTAR TMS THERAPY SYSTEM (Device) | Food and Beverage | Cash or cash equivalent | $10.13 | General |
| Category: NEUROSTAR TMS THERAPY SYSTEM | ||||||
| 11/19/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $31.64 | General |
| Category: Neurology | ||||||
| 11/15/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $25.32 | General |
| Category: Rare Disease | ||||||
| 11/15/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2024 | Lilly USA, LLC | KISUNLA (Drug) | Food and Beverage | In-kind items and services | $16.98 | General |
| Category: Neuroscience | ||||||
| 11/14/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $2.06 | General |
| Category: Neurology | ||||||
| 11/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $89.22 | General |
| Category: Immunology | ||||||
| 11/13/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $44.99 | General |
| Category: Neurology | ||||||
| 11/11/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Immunology | ||||||
| 11/08/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $30.24 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 289 | 633 | $211,522 | $88,125 |
| 2022 | 9 | 427 | 973 | $344,743 | $140,898 |
| 2021 | 7 | 324 | 719 | $274,261 | $109,243 |
| 2020 | 6 | 265 | 761 | $268,347 | $98,050 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 107 | 363 | $118,337 | $54,026 | 45.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 90 | $21,960 | $8,950 | 40.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 39 | 39 | $18,018 | $6,616 | 36.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2023 | 15 | 51 | $10,200 | $4,484 | 44.0% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2023 | 15 | 16 | $18,900 | $4,043 | 21.4% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 26 | 35 | $8,975 | $3,809 | 42.4% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 19 | 19 | $7,372 | $3,389 | 46.0% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 20 | 20 | $7,760 | $2,807 | 36.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 125 | 558 | $181,904 | $83,751 | 46.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 77 | 77 | $35,574 | $12,501 | 35.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 45 | 45 | $17,460 | $8,239 | 47.2% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2022 | 46 | 73 | $17,030 | $8,220 | 48.3% |
| 95913 | Nerve conduction, 13 or more studies | Office | 2022 | 26 | 31 | $46,500 | $8,186 | 17.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Office | 2022 | 26 | 79 | $16,000 | $7,320 | 45.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 30 | 52 | $12,688 | $5,812 | 45.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 34 | 34 | $13,192 | $4,905 | 37.2% |
| 96116 | Exam of neurobehavioral status, first hour | Office | 2022 | 18 | 24 | $4,395 | $1,964 | 44.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 119 | 463 | $150,925 | $70,266 | 46.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 61 | 61 | $28,182 | $10,703 | 38.0% |
| 95913 | Nerve transmission studies, 13 or more studies | Office | 2021 | 30 | 33 | $49,500 | $9,130 | 18.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 46 | 46 | $17,848 | $6,745 | 37.8% |
| 95886 | Needle measurement and recording of electrical activity of muscles of arm or leg complete study | Office | 2021 | 32 | 71 | $14,870 | $6,713 | 45.1% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 19 | 19 | $7,372 | $3,518 | 47.7% |
| 96116 | Neurobehavioral status examination by qualified health care professional with interpretation and report, first 60 minutes | Office | 2021 | 17 | 26 | $5,564 | $2,169 | 39.0% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 120 | 567 | $184,841 | $69,389 | 37.5% |
About Dr. Luz Cano, MD
Dr. Luz Cano, MD is a Internal Medicine healthcare provider based in Newport Beach, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1619993698.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Luz Cano, MD has received a total of $30,466 in payments from pharmaceutical and medical device companies, with $4,433 received in 2024. These payments were reported across 1,256 transactions from 83 companies. The most common payment nature is "Food and Beverage" ($28,643).
As a Medicare-enrolled provider, Cano has provided services to 1,305 Medicare beneficiaries, totaling 3,086 services with total Medicare billing of $436,316. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Neurology
- Location Newport Beach, CA
- Active Since 07/14/2006
- Last Updated 09/20/2019
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1619993698
Products in Payments
- VRAYLAR (Drug) $1,821
- ACTIVA (Device) $1,727
- TYSABRI (Biological) $1,586
- Infinity DBS Pulse Generators (Device) $1,418
- KESIMPTA (Drug) $1,341
- Briviact (Drug) $1,196
- UBRELVY (Drug) $1,190
- INGREZZA (Drug) $888.92
- Rystiggo (Drug) $886.19
- RYTARY (Drug) $767.35
- NURTEC ODT (Drug) $738.36
- Ozempic (Drug) $737.26
- TRINTELLIX (Drug) $631.65
- OCREVUS (Biological) $457.83
- SOLIRIS (Drug) $422.14
- EMGALITY (Drug) $409.50
- BOTOX (Biological) $404.21
- Hizentra (Biological) $382.47
- Victoza (Drug) $352.02
- QULIPTA (Drug) $339.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Newport Beach
Daniel Nadeau, Md, MD
Internal Medicine — Payments: $1.5M
Dr. Ehab Mady, D.o, D.O
Internal Medicine — Payments: $256,298
Ryan Klein, Md, MD
Internal Medicine — Payments: $159,192
Wael Harb, Md, MD
Internal Medicine — Payments: $130,572
Laura Salazar, Md, MD
Internal Medicine — Payments: $129,472
David Brouwer, Md, MD
Internal Medicine — Payments: $71,027